BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37536710)

  • 1. Association between Metabolically Healthy Status and Risk of Gastrointestinal Cancer.
    Cui H; Tian F; Chen Y; Ma X
    Cancer Res Treat; 2024 Jan; 56(1):238-246. PubMed ID: 37536710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Murphy N; Cross AJ; Abubakar M; Jenab M; Aleksandrova K; Boutron-Ruault MC; Dossus L; Racine A; Kühn T; Katzke VA; Tjønneland A; Petersen KE; Overvad K; Quirós JR; Jakszyn P; Molina-Montes E; Dorronsoro M; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Vineis P; Panico S; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Ohlsson B; Ericson U; Palmqvist R; Nyström H; Weiderpass E; Skeie G; Freisling H; Kong SY; Tsilidis K; Muller DC; Riboli E; Gunter MJ
    PLoS Med; 2016 Apr; 13(4):e1001988. PubMed ID: 27046222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.
    Cho YK; Lee J; Kim HS; Park JY; Lee WJ; Kim YJ; Jung CH
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31967306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolically healthy obesity, transition from metabolic healthy to unhealthy status, and carotid atherosclerosis.
    Huang Q; Liu Z; Wei M; Feng J; Huang Q; Liu Y; Liu Z; Li X; Yin L; Xia J
    Diabetes Metab Res Rev; 2024 Feb; 40(2):e3766. PubMed ID: 38351639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitions in metabolic health status over time and risk of heart failure: A prospective study.
    Bi J; Song L; Wang L; Su B; Wu M; Li D; Chen S; Liu Y; Yang Y; Zhou Z; Hu Y; Wang Y; Wu S; Tian Y
    Diabetes Metab; 2022 Jan; 48(1):101266. PubMed ID: 34252500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Obesity Phenotypes and Risk of Lung Cancer: A Prospective Cohort Study of 450,482 UK Biobank Participants.
    Shao F; Chen Y; Xu H; Chen X; Zhou J; Wu Y; Tang Y; Wang Z; Zhang R; Lange T; Ma H; Hu Z; Shen H; Christiani DC; Chen F; Zhao Y; You D
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Metabolic Phenotypes of Body Fatness and Incident Stroke: A Prospective Cohort Study of Chinese Community Residents.
    Tang M; Zhao Q; Yi K; Wu Y; Xiang Y; Zaid M; Cui S; Su X; Yu Y; Zhao G; Jiang Y
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolically healthy obesity was significantly associated with increased risk of gallstones.
    Man S; Gao Y; Lv J; Tong M; Yin J; Wang B; Ning Y; Li L
    Eur J Endocrinol; 2022 Jan; 186(2):275-283. PubMed ID: 34889778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: A cohort study.
    Gao M; Lv J; Yu C; Guo Y; Bian Z; Yang R; Du H; Yang L; Chen Y; Li Z; Zhang X; Chen J; Qi L; Chen Z; Huang T; Li L;
    PLoS Med; 2020 Oct; 17(10):e1003351. PubMed ID: 33125374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of body shape on the development of cardiovascular disease in individuals with metabolically healthy obesity.
    Oh CM; Park JH; Chung HS; Yu JM; Chung W; Kang JG; Moon S
    Medicine (Baltimore); 2020 Sep; 99(38):e22036. PubMed ID: 32957321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic status of metabolically healthy overweight/obesity and metabolically unhealthy and normal weight and the risk of type 2 diabetes mellitus: A cohort study of a rural adult Chinese population.
    Wang B; Zhang M; Wang S; Wang C; Wang J; Li L; Zhang L; Ren Y; Han C; Zhao Y; Zhou J; Wang G; Shen Y; Wu D; Pang C; Yin L; Feng T; Zhao J; Luo X; Hu D
    Obes Res Clin Pract; 2018; 12(1):61-71. PubMed ID: 29100915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolically healthy overweight/obesity and cancer risk: A representative cohort study in Taiwan.
    Lin CJ; Chang YC; Hsu HY; Tsai MC; Hsu LY; Hwang LC; Chien KL; Yeh TL
    Obes Res Clin Pract; 2021; 15(6):564-569. PubMed ID: 34782258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between metabolically healthy obesity and non-alcoholic fatty liver disease.
    Man S; Lv J; Yu C; Deng Y; Yin J; Wang B; Li L; Liu H
    Hepatol Int; 2022 Dec; 16(6):1412-1423. PubMed ID: 35987840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cumulative excess weight and waist circumference exposure with transition from metabolically healthy obesity to metabolically unhealthy.
    Jahromi MK; Ebadinejad A; Barzin M; Mahdavi M; Niroomand M; Khalili D; Valizadeh M; Azizi F; Hosseinpanah F
    Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2544-2552. PubMed ID: 36163212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity Metabolic Phenotype, Changes in Time and Risk of Diabetes Mellitus in an Observational Prospective Study on General Population.
    Yang C; Liu X; Dang Y; Li J; Jing J; Tian D; Qiu J; Zhang J; Yan N; Liu X; Zhao Y; Zhang Y
    Int J Public Health; 2022; 67():1604986. PubMed ID: 36250153
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes.
    Zhao L; Zou Y; Wu Y; Cai L; Zhao Y; Wang Y; Xiao X; Yang Q; Yang J; Ren H; Tong N; Liu F
    Front Endocrinol (Lausanne); 2023; 14():1103251. PubMed ID: 37234807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolically healthy obesity, transition to unhealthy phenotypes, and type 2 diabetes in 0.5 million Chinese adults: the China Kadoorie Biobank.
    Song Z; Gao M; Lv J; Yu C; Guo Y; Bian Z; Wei Y; Yang L; Du H; Chen Y; Zhang J; Yao J; Chen J; Chen Z; Huang T; Li L;
    Eur J Endocrinol; 2022 Jan; 186(2):233-244. PubMed ID: 34874895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study.
    Wei D; González-Marrachelli V; Melgarejo JD; Liao CT; Hu A; Janssens S; Verhamme P; Van Aelst L; Vanassche T; Redon J; Tellez-Plaza M; Martin-Escudero JC; Monleon D; Zhang ZY
    Cardiovasc Diabetol; 2023 Apr; 22(1):82. PubMed ID: 37029406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.